-
psnet.ahrq.gov/node/49810/psn-pdf
November 01, 2017 - This is
particularly relevant in patients with chronic organ failure like ischemic heart disease or renal … Dying of end-stage heart failure and renal failure can be relatively peaceful, but it may also require … In patients with renal failure, hydromorphone is an acceptable choice as it is mainly metabolized
by … In general, and especially for a
geriatric patient with renal insufficiency, opioid treatment should … Palliative care in end-stage renal disease: illness trajectories, communication, and hospice
use.
-
psnet.ahrq.gov/issue/keeping-kidney-patients-safe
September 17, 2020 - providers, and identifies best practice strategies for avoiding the Five Adverse Patient Safety Events in renal
-
psnet.ahrq.gov/web-mm/xl-or-smaller
September 13, 2017 - The Case With a history of hypertension and chronic renal failure secondary to hemolytic uremia syndrome … The intern admitting the patient spoke with the renal fellow to ask for advice concerning the hypertension … The renal fellow recommended giving the patient Procardia® (nifedipine) 30 mg by mouth. … IV fluids were started and the renal fellow was contacted. … When renal specialists refer to the extended-release drug Procardia XL, it is often called Procardia
-
psnet.ahrq.gov/issue/demonstration-project-impact-safety-culture-infection-control-practices-hemodialysis
May 01, 2024 - January 2, 2017
Medication dosing errors for patients with renal insufficiency in ambulatory … January 2, 2017
AHRQ Safety Program for End-Stage Renal Disease Facilities—Toolkit.
-
psnet.ahrq.gov/web-mm/palliative-care-comfort-vs-harm
December 04, 2016 - This is particularly relevant in patients with chronic organ failure like ischemic heart disease or renal … Dying of end-stage heart failure and renal failure can be relatively peaceful, but it may also require … In patients with renal failure, hydromorphone is an acceptable choice as it is mainly metabolized by … In general, and especially for a geriatric patient with renal insufficiency, opioid treatment should … Palliative care in end-stage renal disease: illness trajectories, communication, and hospice use.
-
psnet.ahrq.gov/node/49514/psn-pdf
July 01, 2006 - He had no known renal dysfunction. … are
generally well tolerated, like most drugs, their most worrisome adverse effects (hypotension, renal … dose of the offending drug(s), use of
concomitant therapies, and comorbid illnesses, particularly renal … healthier patients,
systematically excluding those with other risk factors for hyperkalemia (eg, advanced renal … prophylactic doses (eg, 5000 units BID)
Nonsteroidal anti-inflammatory drugs
Patients with compromised renal
-
psnet.ahrq.gov/web-mm/complications-vascular-access-procedures-patients-kidney-disease
November 15, 2023 - Patient 1: A 31-year-old woman with end stage renal disease (ESRD) and pulmonary hypertension presented … some patients have an increased risk for adverse effects due to underlying comorbid conditions such as renal … advanced age, complicated baseline respiratory status, and drug interactions. 8 Given this patient’s poor renal … vascular access procedures but should be used cautiously in patients with comorbid conditions such as renal … WebM&M Cases
Overdose of Gabapentin and Oxycodone in a Patient with End-Stage Renal
-
psnet.ahrq.gov/sites/default/files/2024-08/spotlight_case_a_fatal_twist_in_pseudohyperkalemia_slides.pptx
January 01, 2024 - Potassium (2)
Hypokalemia, defined as serum potassium <3.5 mEq/L, can be caused by decreased intake, renal … changes, rapid-onset or severe hyperkalemia >6.5 mEq/L, or underlying heart disease, cirrhosis, or renal … hypokalemia exacerbated by transcellular shifts (from albuterol, insulin, and sodium bicarbonate), renal … Nonetheless, the physician should have reviewed the EHR to ascertain baseline renal function and any … combination of hyponatremia and hyperkalemia is explained by a limited number of conditions (e.g., renal
-
psnet.ahrq.gov/node/60611/psn-pdf
June 24, 2020 - factors including the indication (atrial fibrillation, VTE treatment, or VTE prevention), level of
renal … syndrome,
when compared with dual antiplatelet treatment. 6
Assessment of DOAC use in End Stage Renal … Relevant variables, such as status of a patient’s renal function, can
be determined from data already … Safety and efficacy of apixaban in
patients with end-stage renal disease: Meta-Analysis. … Pharmacokinetics, pharmacodynamics, and safety of
apixaban in subjects with end-stage renal disease
-
psnet.ahrq.gov/issue/hearing-broken-promises-assessing-vas-systems-protecting-veterans-clinical-harm
December 23, 2012 - September 2, 2016
Hearing on Patient Safety and Quality Issues in End Stage Renal Disease … May 1, 2015
Hearing on Patient Safety and Quality Issues in End Stage Renal Disease Treatment
-
psnet.ahrq.gov/node/49511/psn-pdf
May 01, 2006 - psnet.ahrq.gov/web-mm/citrate-mix
The Case
A 36-year-old woman with multiple sclerosis, diabetes, and chronic renal … In spite of the patient's pre-existing renal disease and diabetes, no permanent harm resulted; the
outcome … example, the Institute for Safe Medication
Practices (ISMP) reported a case of a 15-month-old child with renal … system may be tailored to screen the patient's laboratory
values (serum potassium) and disease states (renal
-
psnet.ahrq.gov/curated-library/diagnostic-errors-case-studies
March 31, 2025 - Read More
Renal Failure Due to Benign Prostatic Hyperplasia … Her white blood cell count was greater than 30,000 and she was found to be in acute renal and liver failure … Renal Failure Due to Benign Prostatic Hyperplasia
Michael J. Barry, MD, and Marc B. … be markedly elevated, 2L of urine were drained via catheter, and he was admitted to the hospital for renal
-
psnet.ahrq.gov/web-mm/one-ace-too-many
June 21, 2016 - He had no known renal dysfunction. … inhibitors are generally well tolerated, like most drugs, their most worrisome adverse effects (hypotension, renal … the dose of the offending drug(s), use of concomitant therapies, and comorbid illnesses, particularly renal … healthier patients, systematically excluding those with other risk factors for hyperkalemia (eg, advanced renal … (eg, 5000 units BID) Nonsteroidal anti-inflammatory drugs Patients with compromised renal
-
psnet.ahrq.gov/node/49795/psn-pdf
June 01, 2017 - However, out of concern for worsening the
renal failure with contrast (i.e., contrast-induced nephropathy … Iodinated
contrast media can cause kidney injury through direct cytotoxic effects on renal tissue.(1 … resulted in a growing
elderly population with comorbidities such as hypertension, diabetes mellitus, renal … disease, and
cardiovascular disease, all of which predispose to renal impairment. … contrast media.(6) The risk in the setting of chronic kidney disease depends on
the degree of baseline renal
-
psnet.ahrq.gov/node/50696/psn-pdf
November 27, 2019 - Patient 1:
A 31-year-old woman with end stage renal disease (ESRD) and pulmonary hypertension presented … patients have an
increased risk for adverse effects due to underlying comorbid conditions such as renal … advanced age, complicated baseline respiratory status, and drug interactions.8 Given this patient’s poor
renal … procedural sedation; however, for patients with comorbid conditions affecting their respiratory
status and renal … vascular access
procedures but should be used cautiously in patients with comorbid conditions such as renal
-
psnet.ahrq.gov/node/73966/psn-pdf
October 13, 2021 - cross-sectional study identified prescribing errors – primarily lack of dosage adjustment for
body weight and/or renal
-
psnet.ahrq.gov/web-mm/direct-oral-anticoagulants-are-high-risk-medications-potentially-complex-dosing
August 21, 2005 - factors including the indication (atrial fibrillation, VTE treatment, or VTE prevention), level of renal … syndrome, when compared with dual antiplatelet treatment. 6
Assessment of DOAC use in End Stage Renal … Relevant variables, such as status of a patient’s renal function, can be determined from data already … Safety and efficacy of apixaban in patients with end-stage renal disease: Meta-Analysis. … Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.332_slideshow.ppt
September 01, 2014 - morphine and hydromorphone, are mainly eliminated in the urine; may need to adjust dose in setting of renal … He was found to have new acute renal insufficiency, which likely had contributed to a build-up of opioids … pubmed/23553809
17
Predictors of Opioid-Related Adverse Events
Patient-related factors
Age
Obesity
Renal … morphine equivalents
Use of multiple opioid drugs
Co-prescription of other sedating medications (diazepam)
Renal … hydromorphone instead of morphine likely contributed
Doses should have been reduced in the setting of renal
-
psnet.ahrq.gov/web-mm/perils-contrast-media
March 01, 2007 - However, out of concern for worsening the renal failure with contrast (i.e., contrast-induced nephropathy … Iodinated contrast media can cause kidney injury through direct cytotoxic effects on renal tissue.( 1 … resulted in a growing elderly population with comorbidities such as hypertension, diabetes mellitus, renal … disease, and cardiovascular disease, all of which predispose to renal impairment. … contrast media.( 6 ) The risk in the setting of chronic kidney disease depends on the degree of baseline renal
-
psnet.ahrq.gov/node/867235/psn-pdf
December 04, 2024 - Common acquired
conditions identified include hemorrhage, sepsis, and respiratory and renal complications